16:02 EDT Actuate Therapeutics (ACTU) files to sell 1.33M shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACTU:
- Promising Clinical Developments and Valuation Support Buy Rating for Actuate Therapeutics
- Actuate Therapeutics announces end of Phase 1 portion of elraglusib study
- Actuate Therapeutics Secures $4.7M in Private Placement
- Actuate highlights results from subgroup analysis of Phase 2 elraglusib trial
- Actuate reports biomarker, machine learning data from Phase 2 elraglusib trial